Profile data is unavailable for this security.
About the company
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
- Revenue in USD (TTM)2.24bn
- Net income in USD40.68m
- Incorporated2003
- Employees5.00k
- LocationGlobus Medical Inc2560 General Armistead AveAUDUBON 19403-5214United StatesUSA
- Phone+1 (610) 930-1800
- Fax+1 (302) 636-5454
- Websitehttps://www.globusmedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TransMedics Group Inc | 358.76m | 3.00m | 5.50bn | 584.00 | 3,999.03 | 28.95 | 316.38 | 15.34 | 0.0413 | 0.0413 | 10.61 | 5.70 | 0.4952 | 3.56 | 5.58 | 614,313.40 | 0.4141 | -16.08 | 0.4403 | -17.95 | 60.71 | 65.37 | 0.8362 | -40.47 | 8.48 | -- | 0.7278 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
| Merit Medical Systems Inc | 1.30bn | 117.43m | 5.80bn | 6.95k | 49.63 | 4.52 | 27.23 | 4.45 | 2.01 | 2.01 | 22.24 | 22.04 | 0.6183 | 2.30 | 7.36 | 187,231.10 | 5.58 | 2.45 | 6.13 | 2.77 | 46.54 | 44.50 | 9.02 | 3.91 | 4.64 | 17.52 | 0.3846 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
| Stevanato Group SpA | 1.21bn | 136.81m | 5.83bn | 5.64k | 37.50 | 3.56 | 25.73 | 4.80 | 0.5136 | 0.5136 | 4.54 | 5.42 | 0.543 | 2.66 | 2.80 | 215,440.70 | 6.12 | -- | 8.34 | -- | 30.06 | -- | 11.27 | -- | 1.13 | 44.77 | 0.1926 | -- | 10.34 | -- | 1.95 | -- | -- | -- |
| Inspire Medical Systems Inc | 705.71m | 6.01m | 6.35bn | 1.01k | 1,099.89 | 9.94 | 644.81 | 8.99 | 0.1935 | 0.1935 | 23.74 | 21.41 | 1.05 | 2.68 | 9.86 | 698,026.70 | 0.8927 | -11.27 | 0.99 | -12.60 | 84.83 | 84.47 | 0.8518 | -13.57 | 8.35 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
| Masimo Corp | 2.02bn | 79.40m | 6.49bn | 3.80k | 82.59 | 4.72 | 37.18 | 3.22 | 1.47 | 1.47 | 37.32 | 25.73 | 0.6831 | 1.94 | 5.77 | 530,763.20 | 2.69 | 8.65 | 3.32 | 10.31 | 49.28 | 57.30 | 3.94 | 12.03 | 1.15 | 3.30 | 0.3635 | 0.00 | 0.6042 | 19.00 | -43.21 | -15.96 | 31.06 | -- |
| Glaukos Corp | 341.73m | -158.61m | 7.02bn | 907.00 | -- | 10.53 | -- | 20.55 | -3.20 | -3.20 | 6.91 | 12.13 | 0.3642 | 1.67 | 7.55 | 376,764.10 | -16.91 | -8.73 | -18.20 | -9.35 | 76.53 | 74.77 | -46.41 | -28.69 | 4.67 | -56.93 | 0.16 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
| Penumbra Inc | 1.13bn | 14.23m | 7.57bn | 4.20k | 571.01 | 6.52 | 174.64 | 6.68 | 0.3415 | 0.3415 | 28.94 | 29.90 | 0.7642 | 1.07 | 5.53 | 269,924.50 | 0.9595 | 2.32 | 1.07 | 2.61 | 65.45 | 63.90 | 1.26 | 3.17 | 3.77 | -- | 0.0209 | 0.00 | 24.95 | 18.93 | 4,643.16 | 68.60 | 9.64 | -- |
| Lantheus Holdings Inc | 1.44bn | 428.48m | 7.64bn | 834.00 | 18.02 | 7.44 | 15.64 | 5.31 | 6.11 | 6.11 | 20.48 | 14.79 | 0.8775 | 8.35 | 4.58 | 1,724,234.00 | 26.15 | 6.69 | 29.96 | 7.73 | 64.49 | 57.56 | 29.80 | 9.02 | 4.41 | -- | 0.3546 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
| Repligen Corp | 602.35m | -1.90m | 8.01bn | 1.78k | -- | 4.02 | 116.73 | 13.29 | -0.0416 | -0.0416 | 10.67 | 35.53 | 0.2226 | 1.46 | 4.95 | 337,831.80 | -0.0703 | 4.38 | -0.0782 | 5.03 | 47.70 | 55.43 | -0.3156 | 15.91 | 5.56 | -- | 0.2282 | 0.00 | -20.31 | 26.91 | -77.64 | 20.13 | 24.99 | -- |
| Henry Schein, Inc. | 12.49bn | 352.00m | 9.02bn | 25.00k | 26.30 | 2.57 | 14.29 | 0.722 | 2.71 | 2.71 | 95.98 | 27.64 | 1.29 | 4.88 | 8.25 | 499,480.00 | 3.58 | 6.09 | 5.97 | 10.44 | 31.63 | 30.04 | 2.78 | 4.40 | 0.896 | 6.85 | 0.3333 | 0.00 | -2.44 | 5.55 | -22.68 | -0.1456 | 21.27 | -- |
| Bio Rad Laboratories Inc | 2.56bn | -1.33bn | 9.18bn | 8.03k | -- | 1.37 | -- | 3.58 | -47.03 | -47.03 | 89.18 | 240.39 | 0.2366 | 1.49 | 5.47 | 319,128.80 | -12.24 | 9.08 | -12.87 | 9.60 | 54.02 | 55.55 | -51.73 | 41.97 | 4.63 | 0.1653 | 0.1504 | 0.00 | -4.67 | 3.13 | 82.43 | -- | 3.83 | -- |
| Globus Medical Inc | 2.24bn | 40.68m | 9.57bn | 5.00k | 237.98 | 2.40 | 35.52 | 4.28 | 0.2968 | 0.2968 | 17.02 | 29.38 | 0.6207 | 1.63 | 5.25 | 447,306.00 | 1.13 | 6.90 | 1.30 | 7.45 | 59.65 | 71.73 | 1.82 | 14.05 | 1.45 | 455.56 | 0.098 | 0.00 | 53.34 | 17.08 | -35.39 | -4.72 | 5.57 | -- |
| Bruker Corp | 3.12bn | 352.10m | 10.23bn | 9.71k | 28.11 | 5.71 | 20.63 | 3.28 | 2.40 | 2.40 | 21.24 | 11.82 | 0.6393 | 1.47 | 5.90 | 321,386.60 | 7.21 | 8.38 | 9.59 | 11.40 | 50.08 | 49.85 | 11.28 | 11.39 | 0.7244 | 43.06 | 0.5419 | 9.81 | 17.14 | 9.36 | 44.03 | 18.91 | 16.79 | 4.56 |
| Teleflex Inc | 3.01bn | 264.76m | 11.43bn | 14.50k | 43.35 | 2.51 | 21.94 | 3.80 | 5.59 | 5.57 | 63.54 | 96.76 | 0.4196 | 2.09 | 6.85 | 207,437.10 | 3.69 | 5.86 | 4.00 | 6.42 | 55.86 | 54.43 | 8.80 | 14.62 | 1.44 | 7.14 | 0.2737 | 15.84 | 6.57 | 3.97 | -1.47 | 12.73 | 2.51 | 0.00 |
Data as of Sep 21 2024. Currency figures normalised to Globus Medical Inc's reporting currency: US Dollar USD
40.91%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2024 | 10.51m | 9.30% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 9.60m | 8.50% |
| Janus Henderson Investors US LLCas of 30 Jun 2024 | 7.32m | 6.48% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 3.49m | 3.09% |
| Wellington Management Co. LLPas of 30 Jun 2024 | 2.94m | 2.60% |
| Burgundy Asset Management Ltd.as of 30 Jun 2024 | 2.51m | 2.23% |
| Camber Capital Management LPas of 30 Jun 2024 | 2.50m | 2.21% |
| JPMorgan Investment Management, Inc.as of 30 Jun 2024 | 2.50m | 2.21% |
| Champlain Investment Partners LLCas of 30 Jun 2024 | 2.47m | 2.18% |
| Hawk Ridge Capital Management LPas of 30 Jun 2024 | 2.37m | 2.10% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
